American Capital Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
American Capital Advisory's PFE Position: Q3 2026 in Review
American Capital Advisory increased its Pfizer (PFE) stake by 3.2% in Q3 2026, buying an estimated $2.42K and bringing the position to 2,933 shares worth $83.6K. The position accounts for 0.03% of the portfolio, ranked #181.
American Capital Advisory first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- American Capital Advisory held 2,933 shares of Pfizer worth $83.6K as of Q3 2026.
- American Capital Advisory bought 91 Pfizer shares in Q3 2026, an estimated $2.42K.
- Pfizer made up 0.03% of American Capital Advisory's portfolio in Q3 2026, its #181 holding.
- American Capital Advisory first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
- 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on American Capital Advisory's 13F filing for Q3 2026, filed 28 Oct 2026.